343 related articles for article (PubMed ID: 18578065)
1. [Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?].
Diener C
MMW Fortschr Med; 2008 May; 150(21):7. PubMed ID: 18578065
[No Abstract] [Full Text] [Related]
2. [ASS plus dipyridamole or clopidogrel after stroke: what is the best secondary prevention?].
Einecke D
MMW Fortschr Med; 2008 May; 150(21):6-7. PubMed ID: 18575244
[No Abstract] [Full Text] [Related]
3. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
[No Abstract] [Full Text] [Related]
4. [Platelet-function inhibitors in the secondary prevention of ischemic stroke].
Busse O; Diener HC; Grond M
Dtsch Med Wochenschr; 2006 Nov; 131 Suppl 5():S132-4. PubMed ID: 17089258
[No Abstract] [Full Text] [Related]
5. [PRoFESS study presented. Change in secondary prevention].
MMW Fortschr Med; 2003 May; 145 Suppl 2():96-7. PubMed ID: 14579494
[No Abstract] [Full Text] [Related]
6. The PRoFESS trial results: what went wrong?
Anderson CS
Int J Stroke; 2008 Aug; 3(3):165-6. PubMed ID: 18705892
[No Abstract] [Full Text] [Related]
7. Newer antiplatelet therapies in stroke prevention.
Davis SM; Donnan GA
Aust Fam Physician; 2001 Feb; 30(2):129-34. PubMed ID: 11280112
[TBL] [Abstract][Full Text] [Related]
8. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Kirshner HS
Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
10. [Combination of acetylsalicylic acid with dipyridamole is better than acetylsalicylic acid monotherapy].
Schindler B
Med Monatsschr Pharm; 2006 Nov; 29(11):421-3. PubMed ID: 17131692
[No Abstract] [Full Text] [Related]
11. [Long-term therapy with clopidogrel in combination with ASA significantly reduces risk of death, myocardial infarct or stroke].
Minerva Med; 2003 Apr; 94(2):XIII-IV. PubMed ID: 12916522
[No Abstract] [Full Text] [Related]
12. [Clopidogrel as basic therapy in high-risk stroke patients].
Mattle HP
Praxis (Bern 1994); 2004 Aug; 93(34):1364. PubMed ID: 15468694
[No Abstract] [Full Text] [Related]
13. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
14. The approach to optimizing stroke care.
Panagos PD
Am J Emerg Med; 2008 Sep; 26(7):808-16. PubMed ID: 18774049
[TBL] [Abstract][Full Text] [Related]
15. Is acetylsalicylic acid plus dipyridamole superior to ASA alone for secondary prevention of stroke?
Dalton B; Papoushek C; Evans MF
Can Fam Physician; 2001 Nov; 47():2235-9. PubMed ID: 11768921
[No Abstract] [Full Text] [Related]
16. Antiplatelet agents. European perspective.
Sivenius J; Kaste M
Adv Neurol; 2003; 92():293-9; discussion 301-5. PubMed ID: 12760196
[No Abstract] [Full Text] [Related]
17. Antiplatelet agents and randomized trials.
Diener HC
Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet agents for prevention of recurrent ischemic stroke.
Hegge KA
S D Med; 2009 Jan; 62(1):15-7. PubMed ID: 19245087
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelets for stroke prevention: implications of the PRoFESS trial.
Selim M
Stroke; 2009 May; 40(5):1936-7. PubMed ID: 19038907
[No Abstract] [Full Text] [Related]
20. Aspirin + clopidogrel therapy: how does your care compare to the evidence?
Simmons BB; Salzman BE
J Fam Pract; 2008 Jan; 57(1):26-32. PubMed ID: 18171566
[No Abstract] [Full Text] [Related]
[Next] [New Search]